Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
May 22, 2024 15:35 ET
|
Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.
Medical Polymer Market worth $60.5 billion by 2029 Globally, at a CAGR of 8.0%, says MarketsandMarkets™
May 21, 2024 04:00 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 21, 2024 (GLOBE NEWSWIRE) -- The Global Medical Polymer Market is projected to grow from USD 41.1 billion in 2024, and it is projected to reach USD 60.5 billion by 2029, at a CAGR of...
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
May 15, 2024 07:32 ET
|
Neuronetics
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Russia Medical Consumables Market Booms to $118.7 Million by 2027: Rising Healthcare Expenditure and Chronic Disease Burden Drive Growth: Ken Research
May 14, 2024 06:19 ET
|
Ken Research
Gurugram, India, May 14, 2024 (GLOBE NEWSWIRE) -- Bandage up for a bonanza! Russia medical consumables market is poised for significant growth, with a projected market size of $118.7 million by...
Kardium visar på utökat kliniskt användningsområde för sin CHS™-coatade Globe-kateter
May 14, 2024 03:54 ET
|
Corline Biomedical AB
Kardium Inc. – en av Corlines kunder, som använder CHS™-ytan på sin Globe-kateter för behandling av hjärtarytmi – meddelar att bolaget med sitt Globe-system framgångsrikt behandlat patienter som lider...
CytoSorbents Reports First Quarter 2024 Results
May 09, 2024 16:17 ET
|
CytoSorbents
CytoSorbents Reports First Quarter 2024 Results
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)
May 06, 2024 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
May 01, 2024 08:31 ET
|
Neuronetics
MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device
April 30, 2024 07:00 ET
|
Vitestro
Vitestro lands $22M to ramp up commercialization efforts for robotic blood draw device